John Cerio
Human Resources Officer chez ORCHARD THERAPEUTICS PLC
Profil
John Cerio is currently the Chief Human Resource Officer at Orchard Therapeutics Plc.
Previously, he worked as the Director-Human Resources Corporate Staff at Bristol Myers Squibb Co. He also served as the Vice President-Human Resources at Agenus, Inc. from 2003 to 2011.
Additionally, he held the position of Global Vice President-Human Resources at PerkinElmer Life Sciences, Inc. Mr. Cerio holds a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University.
Postes actifs de John Cerio
| Sociétés | Poste | Début |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Human Resources Officer | - |
Anciens postes connus de John Cerio
| Sociétés | Poste | Fin |
|---|---|---|
PerkinElmer Life Sciences, Inc.
 PerkinElmer Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology PerkinElmer Life Sciences, Inc. Provided drug discovery, life science research and clinical screening services. It was headquartered in Boston, MA. | Human Resources Officer | - |
| BRISTOL-MYERS SQUIBB COMPANY | Human Resources Officer | - |
| AGENUS INC. | Chief Administrative Officer | - |
Formation de John Cerio
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AGENUS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
PerkinElmer Life Sciences, Inc.
PerkinElmer Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology PerkinElmer Life Sciences, Inc. Provided drug discovery, life science research and clinical screening services. It was headquartered in Boston, MA. | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
